Kmart to pay $32 million to settle drug overbilling allegations



WASHINGTON (Reuters) – Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Friday.

The settlement agreement with the United States is a part of a global $59 million settlement that includes a resolution of state Medicaid and insurance claims against Kmart, the Justice Department said. 

Reporting by Eric Beech; Editing by Mohammad Zargham

Our Standards:The Thomson Reuters Trust Principles.


Previous articleQuake of 5.2 magnitude in southeastern Iran injures at least 23
Next articleRBS to pay $125 million to settle California mortgage bond claims
2446 Bloor Street Lougheed, AB T0B 2V0 [email protected] 780-386-2284


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.